Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT06225180 |
Other study ID # |
021.TRA.2023.D |
Secondary ID |
|
Status |
Recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
June 29, 2023 |
Est. completion date |
June 29, 2024 |
Study information
Verified date |
January 2024 |
Source |
Methodist Health System |
Contact |
Kavya Vinod Mankulangara |
Phone |
214-947-1281 |
Email |
MHSIRB[@]mhd.com |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Breast abscesses are an unfortunate pathology that develop in patients, and treatment is
often painful and unpleasant. The goal of this study is to identify risk factors associated
with failure of aspiration as a primary intervention as opposed to incision and drainage in
the hopes of adequately treating patients at initial presentation.
Description:
The pendulum has now swung toward minimally invasive aspiration as the primary treatment
modality, with multiple studies reporting superior cosmetic results. However, patients in
these studies often required repeat breast aspirations, and sometimes ultimately required
incision and drainage. Aspiration first for treatment of breast abscess may not be a wise
choice for all patients if it results in increased antibiotic days, return to emergency
department (ED)/increased cost, or prolonged pain from multiple procedures. Several studies
have identified varying risk factors for aspiration failure as primary intervention for
breast abscesses. More data is needed to confirm the true risk factors for failure.